Literature DB >> 4028755

Bicarbonate hemodialysis of patients with acute renal failure and severe sepsis.

M F Huyghebaert, J F Dhainaut, J F Monsallier, B Schlemmer.   

Abstract

During hemodialysis (HD), septic patients with acute renal failure (ARF) often exhibit severe hemodynamic instability, with a fall in BP that requires a large-volume infusion or even cessation of dialysis. To investigate the hypothesis that acetate transfer plays a role in the BP decrease, we compared acetate (Ac) and bicarbonate (Bi) HD in ten septic ARF patients. Patients were dialyzed daily for 4 h with a single-pass system and 1.1 m2 cuprophan dialyzers, alternately using Ac and Bi as the dialysate buffer. Heart rate and systemic arterial resistance did not change significantly during use of either buffer, and changes in pulmonary wedge pressure were similar. However, decreases in cardiac output and mean arterial pressure were more pronounced during Ac-HD than during Bi-HD. Rapid correction of metabolic acidosis and a larger decrease of plasma potassium concentration occurred during Bi-HD. These results suggest that Bi-HD was better tolerated than Ac-HD because of changes in myocardial contractility that may be related to different effects on acid-base status and plasma potassium concentrations.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4028755     DOI: 10.1097/00003246-198510000-00013

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  3 in total

1.  Hypotension during intermittent hemodialysis: new insights into an old problem.

Authors:  Frédérique Schortgen
Journal:  Intensive Care Med       Date:  2003-09-12       Impact factor: 17.440

2.  Intermittent hemodialysis in critically ill patients with multiple organ dysfunction syndrome is associated with intestinal intramucosal acidosis.

Authors:  G Van der Schueren; M Diltoer; M Laureys; L Huyghens
Journal:  Intensive Care Med       Date:  1996-08       Impact factor: 17.440

Review 3.  Extracorporeal treatment of acute renal failure in the intensive care unit: a critical view.

Authors:  M Schetz; P M Lauwers; P Ferdinande
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.